More on Alere Q2 results

Alere (NYSE:ALR) Q2 results: Net Revenue: $737.9M (-3.4%): Gross Margin: $339.9M (-11.6%); Operating Loss: (-8.8M) (-119.8%); Net Loss: ($49.6M) (+17.7%); Loss Per Share: ($0.67) (+17.3%); Quick Assets: $399.6M (+10.1%); CF Ops: $19.3M (-28.8%).

Revenues by Business Area: Infectious Disease: $165.6M (+7.0%), Toxicology: $164.7M (-0.7%), Cardiloogy: $101.8M (-14.0%), Diabetes: $94.8M (+14.6%).

No guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs